Home  ›  The Impact of Addiction on the Families: Estimates of Prevalence and Costs

The Impact of Addiction on the Families: Estimates of Prevalence and Costs

Written By Sunday, March 6, 2022 Add Comment Edit

Eczema Stats

eczema prevalence eczema impact on quality of life

Overview

These facts and figures represent a summary of the about current information from published scientific literature regarding the prevalence of eczema and the brunt people living with eczema face every twenty-four hours.

The Big Film

31.half-dozen one thousand thousand people (10.1%) in the U.Due south. have some form of eczema. 1 2

1 in 10 individuals will develop eczema during their lifetime, with prevalence peaking in early on babyhood. 2 3 iv 5 6

People of all skin colors, races and ethnicities tin be affected by eczema 1 :

  • White – 11%
  • African American/blackness – x%
  • Asian or Pacific Islander – 13%
  • Native American – 13%

Prevalence of Childhood & Adult Atopic Dermatitis (Advert)

Approximately ix.six 1000000 U.S. children nether the age of 18 accept AD, and 1-third have moderate to severe illness. 5 vii 8

The prevalence of childhood AD has steadily increased from eight% to ~12% since 1997. iv

An estimated 16.5 million U.S. adults (7.3%) have Advertizing that initially began at >ii years of age, with nearly twoscore% affected by moderate or severe disease. nine

Atopic dermatitis is not solely a disease of childhood onset; 1 in 4 adults report adult-onset of initial symptoms. x xi

Atopic dermatitis affects a like number of male and female person children, still, studies accept shown it is more mutual in developed females than males. 2 5 half-dozen 8 ix 12 13

In the U.South., Advert affects more African-American/black children and European-American children compared to Hispanic children. v seven 12

Although study percentages vary, adults that are multiracial or white tend to have the highest prevalence of atopic dermatitis. 2 9 14

African-American/black and Hispanic children tend to have more than severe AD compared to white children. viii fourteen

Children born outside the U.S. have a fifty% lower take chances of developing Advertisement that increases later on living in the U.S. for 10 years. xv

80% of individuals affected with AD experience illness onset prior to 6 years of historic period, and current data suggests at to the lowest degree eighty% will "outgrow" their Advertisement by adolescence or adulthood. 16 17

Children with more severe, persistent Advertizing have a higher run a risk for prolonged illness, although Advert may persist regardless of severity. 17 18

Impacts of Eczema

Disease Burden & Bloodshed

Itch is the most burdensome symptom of Advertizement, followed past peel redness and dryness. 19 20 21

A recent report of adults with moderate to severe AD found that 70.5% reported severe, unbearable itch in the past ii weeks, 85.eight% reported daily itch, and 62.8% reported itching at least 12 hours per mean solar day. 22

Skin pain is a newly appreciated symptom of Advertizement, with 61% of affected adults reporting pain, 33% experienced pain at least once per week, and 5.2% had hurting daily. 20 23 24

Sleep disturbance occurs in approximately 60% of children with AD, and parents of children with AD are iv to 8 times more than likely to average less than six hours of sleep per night compared with caregivers of healthy children. 25 26

15-thirty% of adults with AD experience slumber-related issues including insomnia, daytime sleepiness and fatigue, and charge per unit sleep disturbance as the 'most' or 'second-most' burdensome symptom. 21 27 28

More than than 55% of adults with moderate-to-severe AD written report inadequate disease control. 29 xxx

One in four adults with AD rate their health as "fair" or "poor"; more than than 16% are "very" or "somewhat" dissatisfied with life. Negative ratings of health and life satisfaction increment with AD severity. 21

Hospitalization due to AD flares and associated infections is associated with an 8.three-yr reduction in lifespan compared to the general population. 31 Outside of hospitalization, the risk for death due to whatsoever cause is slightly increased in people with AD. 32

Eczema has the highest effect on disability-associated life years for patients with peel diseases worldwide. 33

Comorbid Weather

Atopic Conditions

Children with AD often develop other atopic conditions in a typical sequence of food allergy, allergic rhinitis and asthma – known as the atopic march. Some of these weather condition may persist for years, others may resolve with increasing age. 34 35

One in 3 children with AD will additionally develop asthma or allergic rhinitis. The gamble of developing asthma increases with AD severity as more than than 50% of children with severe AD will develop asthma. 35 36 37 38 39

Young children with AD are six times more likely to develop a food allergy compared to children without AD. 40 41 42

More than than 20% of adults with AD too have asthma, and they take a two to four times increased risk for having allergic rhinitis and food allergy. two 43

People with atopic dermatitis are at increased risk of developing serious bacterial, viral and fungal skin infections. 44 45

Autoimmune and Cardiac Disease

AD in adults is associated with other serious chronic conditions that contribute to poor health including diabetes, obesity, autoimmune illness, high blood pressure level and centre disease. Risk for these conditions increases with AD severity. 45 46 47 48

Infections

For hospitalized adults with Ad, the prevalence of serious infections including cutaneous, respiratory and systemic (centre, encephalon, GI, bone) infections is significantly higher compared to those without Advertisement. 49

Ocular Conditions

Adults with Ad have an increased run a risk of heart-related weather condition including conjunctivitis, keratitis, and keratoconus; this risk increases with AD affliction severity. l 51

Neuropsychiatric Conditions

Children with AD are more than probable to be diagnosed with attention deficit hyperactivity disorder (ADHD). 45 52 53 54

Children and adolescents with AD are two to half-dozen times more than likely to have depression, feet or acquit disorder than children without Advertizing. 54 55

Adults with AD have a two-and-a-one-half to three-fold higher run a risk for anxiety or depression that increases with disease severity, yet up to 1-one-half of individuals may go undiagnosed. 9 56 57 58

AD'due south negative touch on mental health ranks greater than that for patients with center affliction, diabetes and high claret force per unit area. 21

Recent studies accept suggested people with AD are up to 44% more probable to exhibit suicidal ideation, and 36% are more than likely to try suicide. 59 sixty 61 62 63

Babyhood Ad has a significant bear on on the emotional and social well-being of parents and caregivers. 64

Lifestyle Impacts

Half of adults with moderate to severe AD indicate that Ad significantly limits their lifestyle; nearly 35% of adults with mild AD also feel some lifestyle limitations. 21

More 1-3rd of people with AD say they "oftentimes" or "always" feel angry or embarrassed by their advent due to the affliction. 65

One-third to one-half of adults with AD avoid social interactions considering of their appearance. 21 66 67

Parents and caregivers of children with AD written report feeling embarrassed about their child'due south advent as well as frustration, helplessness, sadness and guilt due to their child's disease. 68

Children, adolescents and young adults with eczema often feel isolated from their peers due to disease-related lifestyle restrictions. 63 68 69

Pre-boyish girls with Advertisement more oft report dumb self-perceived health than their male person counterparts. 70

One in 4 children and teens with Advert have experienced bullying because of their disease. 63 71

Nigh one-third of adults with AD accept experienced challenges in schoolhouse or their work life, and 14% of adults believed that their academic and/or career progression has been hindered past Advertisement. 66 72

Nearly twoscore% of patients with eczema reported that they turned down a job or an educational opportunity due to their disease. 14 73

More than 85% of people with Advertizing indicate their disease affects the type of clothes worn by "somewhat" or "a lot." Girls report more than problems with clothing choices than boys. 67 74

One in three adults with AD and their partners have reported that eczema interfered with establishing relationships and their sexual health. 66 75 76

Economical & Societal Impact

Adults with Advert, regardless of illness severity, are more likely to take five or more days off work annually compared to their non-affected coworkers. 77

Nearly v.9 one thousand thousand workdays annually are lost due to eczema. 77

People with Advertisement have college overall piece of work damage compared to non-affected coworkers. Approximately 15% of the workday tin can be impacted past disease flares. 28 66

Parents of children with AD experience lost work productivity that relates to their kid's Advertising severity. xiv

U.South. adults with moderate to severe AD accept nearly 16% less employment than those with mild AD. 78

People with AD have increased health intendance utilization than those without AD including: seven 77 79

  • $371-$489 higher out-of-pocket costs per person each twelvemonth, which is higher than the out-of-pocket costs for hypertension and diabetes. 77
  • More outpatient doctor visits 28 80 81
  • More visits to urgent/emergency care 82
  • More than hospitalizations 77 83

Cost of care considerations have been reported for Advertising patients: 77

  • 17.6% delayed intendance due to concerns about cost
  • xiii.i% did not seek care due to concerns about cost
  • fifteen.7% report an inability to cover the cost of prescriptions

Inpatient costs for Ad care reach nearly $8.3 one thousand thousand/year for adults and more than $3.3 million/year for children. 84

Full direct medical costs in 2013 averaged $11,660 per AD patient, which represents an incremental cost of $3,302 annually. Costs are higher in patients with more astringent disease. 81

In 2013, the cost to the health system to care for atopic dermatitis patients was $314 1000000. 85

The almanac economic brunt of eczema, including straight medical costs, indirect costs from lost productivity, and quality of life impacts, is conservatively estimated at $v.3 billion. 86

References

  1. Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group. A population-based survey of eczema prevalence in the United states. Dermatitis. 2007;eighteen(2):82-91.[↩][↩]
  2. Silverberg JI, Hanifin JM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol. 2013;132(5):1132-1138.[↩][↩][↩][↩][↩]
  3. Abuabara K, Magyari A, McCulloch CE, Linos E, Margolis DJ, Langan SM. Prevalence of Atopic Eczema Among Patients Seen in Primary Intendance: Data From The Health Improvement Network. Ann Intern Med. 2018.[↩]
  4. Silverberg JI. Public Health Brunt and Epidemiology of Atopic Dermatitis. Dermatol Clin. 2017;35(3):283-289.[↩][↩]
  5. Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: information from the 2003 National Survey of Children'due south Health. J Invest Dermatol. 2011;131(ane):67-73.[↩][↩][↩][↩]
  6. Al-Naqeeb J, Danner Southward, Fagnan LJ, et al. The Burden of Childhood Atopic Dermatitis in the Primary Care Setting: A Report from the Meta-LARC Consortium. J Am Board Fam Med. 2019;32(two):191-200.[↩][↩]
  7. Silverberg JI, Simpson EL. Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization. Pediatr Allergy Immunol. 2013;24(5):476-486.[↩][↩][↩]
  8. Silverberg JI, Simpson EL. Associations of childhood eczema severity: a US population-based study. Dermatitis. 2014;25(3):107-114.[↩][↩][↩]
  9. Chiesa Fuxench ZC, Block JK, Boguniewicz M, et al. Atopic Dermatitis in America Written report: A Cantankerous-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the United states Adult Population. J Invest Dermatol. 2019;139(3):583-590.[↩][↩][↩][↩]
  10. Abuabara M, Yu AM, Okhovat JP, Allen IE, Langan SM. The prevalence of atopic dermatitis beyond babyhood: A systematic review and meta-analysis of longitudinal studies. Allergy. 2018;73(3):696-704.[↩]
  11. Lee HH, Patel KR, Singam V, Rastogi S, Silverberg JI. A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis. J Am Acad Dermatol. 2019;80(6):1526-1532 e1527.[↩]
  12. Silverberg JI, Hanifin J, Simpson EL. Climatic factors are associated with babyhood eczema prevalence in the United States. J Invest Dermatol. 2013;133(vii):1752-1759.[↩][↩]
  13. Barbarot Southward, Auziere S, Gadkari A, et al. Epidemiology of atopic dermatitis in adults: Results from an international survey. Allergy. 2018;73(6):1284-1293.[↩]
  14. Chung J, Simpson EL. The socioeconomics of atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122(4):360-366.[↩][↩][↩][↩]
  15. Silverberg JI, Simpson EL, Durkin HG, Joks R. Prevalence of allergic disease in strange-built-in American children. JAMA Pediatr. 2013;167(vi):554-560.[↩]
  16. Weidinger Southward, Beck LA, Bieber T, Kabashima 1000, Irvine AD. Atopic dermatitis. Nat Rev Dis Primers. 2018;4(1):1.[↩]
  17. Kim JP, Chao LX, Simpson EL, Silverberg JI. Persistence of atopic dermatitis (Advertisement): A systematic review and meta-analysis. J Am Acad Dermatol. 2016;75(4):681-687 e611.[↩][↩]
  18. Margolis JS, Abuabara K, Bilker W, Hoffstad O, Margolis DJ. Persistence of balmy to moderate atopic dermatitis. JAMA Dermatol. 2014;150(vi):593-600.[↩]
  19. Dawn A, Papoiu Ad, Chan YH, Rapp SR, Rassette N, Yosipovitch Grand. Crawling characteristics in atopic dermatitis: results of a web-based questionnaire. Br J Dermatol. 2009;160(3):642-644.[↩]
  20. Maarouf M, Kromenacker B, Capozza KL, et al. Hurting and Itch Are Dual Burdens in Atopic Dermatitis. Dermatitis. 2018;29(5):278-281.[↩][↩]
  21. Silverberg JI, Gelfand JM, Margolis DJ, et al. Patient burden and quality of life in atopic dermatitis in US adults: A population-based cantankerous-sectional report. Ann Allergy Asthma Immunol. 2018;121(3):340-347.[↩][↩][↩][↩][↩][↩]
  22. Simpson EL, Bieber T, Eckert L, et al. Patient burden of moderate to astringent atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults. J Am Acad Dermatol. 2016;74(3):491-498.[↩]
  23. Silverberg JI, Gelfand JM, Margolis DJ, et al. Hurting Is a Mutual and Burdensome Symptom of Atopic Dermatitis in U.s.a. Adults. J Allergy Clin Immunol Pract. 2019.[↩]
  24. Vakharia PP, Chopra R, Sacotte R, et al. Brunt of pare hurting in atopic dermatitis. Ann Allergy Asthma Immunol. 2017;119(half-dozen):548-552 e543.[↩]
  25. Chamlin SL, Mattson CL, Frieden IJ, et al. The price of pruritus: slumber disturbance and cosleeping in atopic dermatitis. Arch Pediatr Adolesc Med. 2005;159(eight):745-750.[↩]
  26. Meltzer LJ, Booster GD. Sleep Disturbance in Caregivers of Children With Respiratory and Atopic Disease. J Pediatr Psychol. 2016;41(six):643-650.[↩]
  27. Silverberg JI, Garg NK, Paller AS, Fishbein AB, Zee PC. Sleep disturbances in adults with eczema are associated with impaired overall wellness: a U.s. population-based study. J Invest Dermatol. 2015;135(one):56-66.[↩]
  28. Eckert 50, Gupta S, Amand C, Gadkari A, Mahajan P, Gelfand JM. Touch on of atopic dermatitis on wellness-related quality of life and productivity in adults in the United States: An assay using the National Wellness and Wellness Survey. J Am Acad Dermatol. 2017;77(ii):274-279 e273.[↩][↩][↩]
  29. Simpson EL, Guttman-Yassky E, Margolis DJ, et al. Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Illness Brunt in Adults With Atopic Dermatitis. JAMA Dermatol. 2018;154(8):903-912.[↩]
  30. Wei W, Anderson P, Gadkari A, et al. Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis. J Dermatol. 2018;45(2):150-157.[↩]
  31. Egeberg A, Skov 50, Andersen YMF, et al. Ten-year mortality is increased after hospitalization for atopic dermatitis compared with the full general population, but reduced compared with psoriasis. J Am Acad Dermatol. 2017;76(1):98-105.[↩]
  32. Thyssen JP, Skov L, Egeberg A. Crusade-specific mortality in adults with atopic dermatitis. J Am Acad Dermatol. 2018;78(iii):506-510.[↩]
  33. Karimkhani C, Dellavalle RP, Coffeng LE, et al. Global Skin Disease Morbidity and Mortality: An Update From the Global Brunt of Disease Study 2013. JAMA Dermatol. 2017;153(5):406-412.[↩]
  34. Barnetson RS, Rogers M. Babyhood atopic eczema. BMJ. 2002;324(7350):1376-1379.[↩]
  35. Spergel JM. Epidemiology of atopic dermatitis and atopic march in children. Immunol Allergy Clin North Am. 2010;30(three):269-280.[↩][↩]
  36. van der Hulst AE, Klip H, Brand PL. Gamble of developing asthma in young children with atopic eczema: a systematic review. J Allergy Clin Immunol. 2007;120(three):565-569.[↩]
  37. Ricci Grand, Patrizi A, Baldi East, Menna G, Tabanelli Thousand, Masi Thou. Long-term follow-up of atopic dermatitis: retrospective analysis of related risk factors and clan with concomitant allergic diseases. J Am Acad Dermatol. 2006;55(5):765-771.[↩]
  38. Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis–a prospective follow-upwards to 7 years of age. Allergy. 2000;55(3):240-245.[↩]
  39. Kapoor R, Menon C, Hoffstad O, Bilker W, Leclerc P, Margolis DJ. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. J Am Acad Dermatol. 2008;58(1):68-73.[↩]
  40. Tsakok T, Marrs T, Mohsin Chiliad, et al. Does atopic dermatitis cause food allergy? A systematic review. J Allergy Clin Immunol. 2016;137(4):1071-1078.[↩]
  41. Hill DA, Spergel JM. The atopic march: Critical evidence and clinical relevance. Ann Allergy Asthma Immunol. 2018;120(2):131-137.[↩]
  42. Eigenmann PA, Sicherer SH, Borkowski TA, Cohen BA, Sampson HA. Prevalence of IgE-mediated food allergy amid children with atopic dermatitis. Pediatrics. 1998;101(3):E8.[↩]
  43. Silverberg JI. Comorbidities and the bear on of atopic dermatitis. Ann Allergy Asthma Immunol. 2019;123(2):144-151.[↩]
  44. Simpson EL. Comorbidity in Atopic Dermatitis. Curr Dermatol Rep. 2012;1(1):29-38.[↩]
  45. Paller A, Jaworski JC, Simpson EL, et al. Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders. Am J Clin Dermatol. 2018;19(6):821-838.[↩][↩][↩]
  46. Silverberg JI, Gelfand JM, Margolis DJ, et al. Clan of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in U.s.a. adults. Ann Allergy Asthma Immunol. 2018;121(5):604-612 e603.[↩]
  47. Ascott A, Mulick A, Yu AM, et al. Atopic eczema and major cardiovascular outcomes: A systematic review and meta-analysis of population-based studies. J Allergy Clin Immunol. 2019;143(5):1821-1829.[↩]
  48. Silverwood RJ, Forbes HJ, Abuabara K, et al. Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular illness: population based accomplice study. BMJ. 2018;361:k1786.[↩]
  49. Narla S, Silverberg JI. Association between atopic dermatitis and serious cutaneous, multiorgan and systemic infections in Usa adults. Ann Allergy Asthma Immunol. 2018;120(1):66-72 e11.[↩]
  50. Thyssen JP, Toft PB, Halling-Overgaard Every bit, Gislason GH, Skov L, Egeberg A. Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis. J Am Acad Dermatol. 2017;77(2):280-286 e281.[↩]
  51. Beck KM, Seitzman GD, Yang EJ, Sanchez IM, Liao W. Ocular Co-Morbidities of Atopic Dermatitis. Part I: Associated Ocular Diseases. Am J Clin Dermatol. 2019.[↩]
  52. Strom MA, Fishbein AB, Paller Equally, Silverberg JI. Association between atopic dermatitis and attention arrears hyperactivity disorder in U.S. children and adults. Br J Dermatol. 2016;175(five):920-929.[↩]
  53. Tsai JD, Chang SN, Mou CH, Sung FC, Lue KH. Association between atopic diseases and attention-deficit/hyperactivity disorder in babyhood: a population-based case-control study. Ann Epidemiol. 2013;23(4):185-188.[↩]
  54. Yaghmaie P, Koudelka CW, Simpson EL. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol. 2013;131(ii):428-433.[↩][↩]
  55. Garg N, Silverberg JI. Association between babyhood allergic disease, psychological comorbidity, and injury requiring medical attending. Ann Allergy Asthma Immunol. 2014;112(6):525-532.[↩]
  56. Silverberg JI, Gelfand JM, Margolis DJ, et al. Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults. Br J Dermatol. 2019.[↩]
  57. Yu SH, Silverberg JI. Association between Atopic Dermatitis and Depression in US Adults. J Invest Dermatol. 2015;135(12):3183-3186.[↩]
  58. Cheng BT, Silverberg JI. Depression and psychological distress in US adults with atopic dermatitis. Ann Allergy Asthma Immunol. 2019;123(ii):179-185.[↩]
  59. Sandhu JK, Wu KK, Bui TL, Armstrong AW. Association Between Atopic Dermatitis and Suicidality: A Systematic Review and Meta-analysis. JAMA Dermatol. 2019;155(2):178-187.[↩]
  60. Patel KR, Immaneni Southward, Singam V, Rastogi S, Silverberg JI. Association between atopic dermatitis, depression, and suicidal ideation: A systematic review and meta-analysis. J Am Acad Dermatol. 2019;lxxx(2):402-410.[↩]
  61. Ronnstad ATM, Halling-Overgaard AS, Hamann CR, Skov 50, Egeberg A, Thyssen JP. Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta-analysis. J Am Acad Dermatol. 2018;79(iii):448-456 e430.[↩]
  62. Drucker AM, Thiruchelvam D, Redelmeier DA. Eczema and subsequent suicide: a matched case-control study. BMJ Open. 2018;8(11):e023776.[↩]
  63. Halvorsen JA, Lien L, Dalgard F, Bjertness E, Stern RS. Suicidal ideation, mental health bug, and social function in adolescents with eczema: a population-based study. J Invest Dermatol. 2014;134(7):1847-1854.[↩][↩][↩]
  64. Yang EJ, Beck KM, Sekhon S, Bhutani T, Koo J. The impact of pediatric atopic dermatitis on families: A review. Pediatr Dermatol. 2019;36(1):66-71.[↩]
  65. Anderson RT, Rajagopalan R. Furnishings of allergic dermatosis on health-related quality of life. Curr Allergy Asthma Rep. 2001;one(4):309-315.[↩]
  66. Zuberbier T, Orlow SJ, Paller AS, et al. Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol. 2006;118(1):226-232.[↩][↩][↩][↩]
  67. Paller AS, McAlister RO, Doyle JJ, Jackson A. Perceptions of physicians and pediatric patients about atopic dermatitis, its impact, and its treatment. Clin Pediatr (Phila). 2002;41(v):323-332.[↩][↩]
  68. Chamlin SL, Frieden IJ, Williams ML, Chren MM. Furnishings of atopic dermatitis on young American children and their families. Pediatrics. 2004;114(three):607-611.[↩][↩]
  69. Roosta North, Black DS, Peng D, Riley LW. Pare illness and stigma in emerging machismo: impact on healthy development. J Cutan Med Surg. 2010;14(6):285-290.[↩]
  70. Ballardini N, Ostblom Eastward, Wahlgren CF, Kull I. Mild eczema affects self-perceived wellness amid pre-adolescent girls. Acta Derm Venereol. 2014;94(3):312-316.[↩]
  71. Magin P, Adams J, Heading Thousand, Pond D, Smith Westward. Experiences of appearance-related teasing and bullying in skin diseases and their psychological sequelae: results of a qualitative study. Scand J Caring Sci. 2008;22(3):430-436.[↩]
  72. von Kobyletzki LB, Beckman L, Smirnova J, et al. Eczema and educational attainment: a systematic review. Br J Dermatol. 2017;177(iii):e47-e49.[↩]
  73. Holm EA, Esmann S, Jemec GB. The handicap acquired by atopic dermatitis–sick leave and job avoidance. J Eur Acad Dermatol Venereol. 2006;xx(3):255-259.[↩]
  74. Hon KL, Leung TF, Wong KY, Chow CM, Chuh A, Ng PC. Does age or gender influence quality of life in children with atopic dermatitis? Clin Exp Dermatol. 2008;33(6):705-709.[↩]
  75. Misery Fifty, Finlay AY, Martin N, et al. Atopic dermatitis: touch on on the quality of life of patients and their partners. Dermatology. 2007;215(two):123-129.[↩]
  76. Misery L, Seneschal J, Reguiai Z, et al. The touch of atopic dermatitis on sexual wellness. J Eur Acad Dermatol Venereol. 2019;33(2):428-432.[↩]
  77. Silverberg JI. Wellness Intendance Utilization, Patient Costs, and Access to Care in US Adults With Eczema: A Population-Based Study. JAMA Dermatol. 2015;151(7):743-752.[↩][↩][↩][↩][↩][↩]
  78. Eckert Fifty, Gupta Southward, Amand C, Gadkari A, Mahajan P, Gelfand JM. The brunt of atopic dermatitis in U.s.a. adults: Wellness care resource utilization data from the 2013 National Health and Health Survey. J Am Acad Dermatol. 2018;78(1):54-61 e51.[↩]
  79. Silverberg JI, Gelfand JM, Margolis DJ, et al. Atopic Dermatitis in US Adults: From Population to Health Care Utilization. J Allergy Clin Immunol Pract. 2019;7(v):1524-1532 e1522.[↩]
  80. Singh P, Silverberg JI. Outpatient utilization patterns for atopic dermatitis in the Us. J Am Acad Dermatol. 2019.[↩]
  81. Drucker AM, Qureshi AA, Amand C, et al. Health Care Resource Utilization and Costs Among Adults with Atopic Dermatitis in the U.s.a.: A Claims-Based Analysis. J Allergy Clin Immunol Pract. 2018;6(4):1342-1348.[↩][↩]
  82. Kwa L, Silverberg JI. Fiscal burden of emergency department visits for atopic dermatitis in the Us. J Am Acad Dermatol. 2018;79(3):443-447.[↩]
  83. Cheng BT, Silverberg JI. Predictors of hospital readmission in Usa children and adults with atopic dermatitis. Ann Allergy Asthma Immunol. 2019;123(1):64-69 e62.[↩]
  84. Narla S, Hsu DY, Thyssen JP, Silverberg JI. Predictors of Hospitalization, Length of Stay, and Costs of Care Among Adult and Pediatric Inpatients With Atopic Dermatitis in the United States. Dermatitis. 2018;29(1):22-31.[↩]
  85. Lim HW, Collins SAB, Resneck JS, Jr., et al. The burden of pare disease in the United States. J Am Acad Dermatol. 2017;76(five):958-972 e952.[↩]
  86. Drucker AM, Wang AR, Li WQ, Sevetson Due east, Block JK, Qureshi AA. The Brunt of Atopic Dermatitis: Summary of a Written report for the National Eczema Association. J Invest Dermatol. 2017;137(one):26-30.[↩]

warnkebaccumare.blogspot.com

Source: https://nationaleczema.org/research/eczema-facts/

0 Response to "The Impact of Addiction on the Families: Estimates of Prevalence and Costs"

Post a Comment

Subscribe to: Post Comments (Atom)

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel